Funding for this research was provided by:
National Health and Medical Research Council (APP1130013, APP1108043)
Prostate Cancer Foundation of Australia
Received: 28 November 2017
Accepted: 1 May 2018
First Online: 24 May 2018
Ethics approval and consent to participate
: None of the prostate cancer cell lines used in this study required institutional human ethics approval. Only the collection of bone marrow aspirate donations required human ethics approval. Ethical approval was granted through the Mater Health Services Human Research Ethics Committee and Queensland University of Technology Ethics Committee (number: 1000000938), in accordance with the Australian National Health and Medical Research Council’s Statement on Ethical Conduct in Research Involving Humans. Volunteer bone marrow donors were informed, and provided written consent prior to participating.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.